» Authors » Elisabeth Rushing

Elisabeth Rushing

Explore the profile of Elisabeth Rushing including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 2549
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Harnisch K, Consuegra A, Okuducu A, Reisch R, Frank S, Hench J, et al.
J Neurosurg Case Lessons . 2025 Mar; 9(10). PMID: 40064002
Background: Glioblastoma (GBM) with a primitive neuronal component (PNC) is a recently characterized subtype with a characteristic (epi-)genetic profile and ambiguous microscopic features mimicking a metastasis, making intraoperative diagnosis challenging....
2.
Reinert M, Kolenc D, Rushing E, Fischmann A, Reinert V
J Neurosurg Case Lessons . 2024 Jul; 8(2). PMID: 38976924
Background: Cavernous malformations of the dura, especially of the tentorium, are exceedingly rare. In the available literature, only 10 cases have been described to date. Observations: The authors present the...
3.
Hench J, Hultschig C, Brugger J, Mariani L, Guzman R, Soleman J, et al.
Acta Neuropathol Commun . 2024 Apr; 12(1):51. PMID: 38576030
DNA methylation analysis based on supervised machine learning algorithms with static reference data, allowing diagnostic tumour typing with unprecedented precision, has quickly become a new standard of care. Whereas genome-wide...
4.
Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti R, et al.
Eur J Cancer . 2023 Jun; 189:112913. PMID: 37277265
Background: Median survival with glioblastoma remains in the range of 12 months on population levels. Only few patients survive for more than 5 years. Patient and disease features associated with...
5.
Kros J, Rushing E, Uwimana A, Hernandez-Lain A, Michotte A, Al-Hussaini M, et al.
Neuro Oncol . 2022 Dec; 25(8):1443-1449. PMID: 36571817
Background: Gliomas with IDH1/2 mutations without 1p19q codeletion have been identified as the distinct diagnostic entity of IDH mutant astrocytoma (IDHmut astrocytoma). Homozygous deletion of Cyclin-dependent kinase 4 inhibitor A/B...
6.
Wang J, Weiss T, Neidert M, Toussaint N, Naghavian R, Selles Moreno C, et al.
Clin Cancer Res . 2022 Oct; 28(24):5368-5382. PMID: 36228153
Purpose: The low mutational load of some cancers is considered one reason for the difficulty to develop effective tumor vaccines. To overcome this problem, we developed a strategy to design...
7.
Bakos E, Nemet O, Kucsma N, Tokesi N, Stieger B, Rushing E, et al.
Front Pharmacol . 2022 Sep; 13:958023. PMID: 36120371
Organic anion transporting polypeptide 3A1 (OATP3A1, encoded by the gene) is a prostaglandin, oligopeptide, and steroid/thyroid hormone transporter with wide tissue distribution, expressed, e.g., in the human brain and testis....
8.
Buehler M, Yi X, Ge W, Blattmann P, Rushing E, Reifenberger G, et al.
Neuro Oncol . 2022 Jul; 25(2):290-302. PMID: 35802605
Background: Recent efforts have described the evolution of glioblastoma from initial diagnosis to post-treatment recurrence on a genomic and transcriptomic level. However, the evolution of the proteomic landscape is largely...
9.
Rosler W, Bink A, Bissig M, Imbach L, Marques Maggio E, Manz M, et al.
Hemasphere . 2022 Jun; 6(7):e733. PMID: 35747591
No abstract available.
10.
Schmid S, Solomon D, Perez E, Thieme A, Kleinschmidt-DeMasters B, Giannini C, et al.
Acta Neuropathol . 2021 Oct; 142(6):1025-1043. PMID: 34661724
Pituicytoma (PITUI), granular cell tumor (GCT), and spindle cell oncocytoma (SCO) are rare tumors of the posterior pituitary. Histologically, they may be challenging to distinguish and have been proposed to...